(Q44598592)

4 December 2017

Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis (English)

1 reference

4 December 2017

0 references

0 references

8

Joaquín Arenas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512887

15 March 2024

author name string

Mercedes Pérez-Carreras

1

1 reference

4 December 2017

Pilar Del Hoyo

2

1 reference

4 December 2017

Ana Martín

5

1 reference

4 December 2017

Gregorio Castellano

6

1 reference

4 December 2017

Francisco Colina

7

1 reference

4 December 2017

Miguel A. Martín

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512887

15 March 2024

Juan C. Rubio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512887

15 March 2024

José A. Solis-Herruzo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512887

15 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

1 reference

4 December 2017

38

1 reference

4 December 2017

999-1007

1 reference

4 December 2017

4

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

4 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Nonalcoholic fatty liver disease: an agenda for clinical research

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Mitochondrial respiratory chain disorders and the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Thyroid hormone regulates oxidative phosphorylation in the cerebral cortex and striatum of neonatal rats.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Guidelines for healthy weight

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

The homeostasis model in the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Carnitine--metabolism and functions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Increased liver carnitine content in obese women.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Free and total carnitine and acylcarnitine content of plasma, urine, liver and muscle of alcoholics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Two novel gene mutations (Glu174-->Lys, Phe383-->Tyr) causing the "hepatic" form of carnitine palmitoyltransferase II deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Mitochondrial abnormalities in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Tumor Necrosis Factor-α Increases the Steady-state Reduction of Cytochromebof the Mitochondrial Respiratory Chain in Metabolically Inhibited L929 Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Mitochondrial diseases in man and mouse

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Hydroxyl radicals and DNA base damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Mitochondrial Disorders

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Oxidative DNA damage, antioxidants, and cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380426

7 January 2021

1

55

342

Ludwig

1980

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

American Journal of Physiology

15 March 2024

9

282

g193

Pessayre

2002

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

The New England Journal of Medicine

15 March 2024

18

341

427

Willett

1999

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

15 March 2024

24

75

437

De Sousa

1988

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

The New England Journal of Medicine

15 March 2024

41

343

1467

Tilg

2000

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

Journal of Clinical Investigation

15 March 2024

45

95

2111

Kern

1995

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50398

15 March 2024

Identifiers

10.1002/HEP.1840380426

1 reference

4 December 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512887

15 March 2024

1 reference